AI assistant
Co-Diagnostics, Inc. — Director's Dealing 2020
Jun 8, 2020
35011_dirs_2020-06-08_d52b30e6-07ba-44d7-a818-41c5adb2e5c7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2020-05-20
Reporting Person: Durenard Eugene (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-05-20 | Common Stock | S | 25000 | $18.03 | Disposed | 25000 | Direct |
| 2020-05-26 | Common Stock | S | 25000 | $18.24 | Disposed | 0 | Direct |
Footnotes
F1: $18.03 is the weighted average price for a range of purchases between $17.90 and $18.63. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. The original Form 4, filed on June 5, 2020, was filed as a result of the printer's error and without authorization. As a result of this administrative error, the weighted average price was misreported.
F2: $18.24 is the volume-weighted average price for a range of purchases between $18.17 and $18.34. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. The original Form 4, filed on June 5, 2020, was filed as a result of the printer's error and without authorization. As a result of this administrative error, the weighted average price was misreported.